According to Divis Laboratories's latest financial reports the company has NZ$0.75 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | NZ$0.80 B | 54.85% |
2022-03-31 | NZ$0.51 B | 27.77% |
2021-03-31 | NZ$0.40 B | 79.39% |
2020-03-31 | NZ$0.22 B | -24.26% |
2019-03-31 | NZ$0.29 B | -26.42% |
2018-03-31 | NZ$0.40 B | 11.57% |
2017-03-31 | NZ$0.36 B | 101.5% |
2016-03-31 | NZ$0.18 B | 11.9% |
2015-03-31 | NZ$0.16 B | 61.85% |
2014-03-31 | NZ$99.73 M | 7.86% |
2013-03-31 | NZ$92.46 M | -21.99% |
2012-03-31 | NZ$0.11 B | -33.1% |
2011-03-31 | NZ$0.17 B | 3309.09% |
2010-03-31 | NZ$5.19 M | 0% |
2009-03-31 | NZ$5.19 M | 14.54% |
2008-03-31 | NZ$4.53 M | -23.57% |
2007-03-31 | NZ$5.93 M | 54.37% |
2006-03-31 | NZ$3.84 M |